Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL

BACKGROUND: Tumour cell-selective activation of apoptosis by recombinant human TNF-related apoptosis-inducing ligand (rhTRAIL) is enhanced through co-activation of p53 by chemotherapeutic drugs. The novel anticancer agent nutlin-3 provides a promising alternative for p53 activation by disrupting the...

Descripción completa

Detalles Bibliográficos
Autores principales: Meijer, A, Kruyt, F A E, van der Zee, A G J, Hollema, H, Le, P, ten Hoor, K A, Groothuis, G M M, Quax, W J, de Vries, E G E, de Jong, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833221/
https://www.ncbi.nlm.nih.gov/pubmed/24136147
http://dx.doi.org/10.1038/bjc.2013.636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833221/
https://www.ncbi.nlm.nih.gov/pubmed/24136147
http://dx.doi.org/10.1038/bjc.2013.636

Ejemplares similares